Intramyocellular lipid quantification: comparison between 3.0- and 1.5-T (1)H-MRS

Area of Science:

• Biomedical Engineering
• Magnetic Resonance Imaging
• Metabolic Research

Background:

• Intramyocellular lipids (IMCL) are crucial biomarkers for metabolic health.
• Proton magnetic resonance spectroscopy ((1)H-MRS) is a key technique for quantifying IMCL.
• Advancements in magnetic resonance (MR) technology aim to improve IMCL measurement precision.

Purpose of the Study:

• To prospectively compare the measurement precision of calf IMCL quantification at 3.0 T versus 1.5 T using (1)H-MRS.
• To evaluate the impact of higher magnetic field strength on IMCL measurement accuracy and reliability.

Main Methods:

• Prospective study involving 15 healthy adult males.
• Single-voxel, short-echo-time, point-resolved (1)H-MRS performed on soleus and tibialis anterior muscles at 1.5 T and 3.0 T.
• IMCL quantification using LCModel, with water peak signal-to-noise ratio (SNR) and full width at half maximum (FWHM) measured via jMRUI.

Main Results:

• No significant difference in interexamination coefficients of variation (CV) for soleus IMCL between 1.5 T and 3.0 T.
• Tibialis anterior (TA) muscle showed significantly higher CVs for IMCL at 3.0 T compared to 1.5 T.
• While SNR increased significantly at 3.0 T, FWHM also increased, indicating no net improvement in measurement precision.

Conclusions:

• Current (1)H-MRS technology at 3.0 T does not offer improved measurement precision for calf IMCL compared to 1.5 T.
• Higher magnetic field strength did not translate to enhanced reliability in IMCL quantification in this study.
• Further technological development may be needed to leverage the benefits of 3.0 T for IMCL measurements.